Immune Biosolutions inc.

Immune Biosolutions is a biotechnology company based in Sherbrooke, Québec, Canada, specializing in the discovery, engineering, and biomanufacturing of clinical-grade antibodies. The company works with clients to develop tailored antibody solutions for therapeutic and diagnostic applications, including projects involving complex protein targets. Its approach uses the avian immune system to generate new antibodies suited to specific research and development needs.

Immune Biosolutions offers services spanning immunization, antibody discovery and selection, and the production of antibodies and proteins. Its engineering capabilities include humanization, affinity maturation, codon optimization, antibody characterization, and the development of bispecific and multispecific antibodies. The company also provides VHH antibody discovery, polyclonal antibodies, and biomanufacturing services.

Through these capabilities, Immune Biosolutions supports partners seeking to advance antibody development and build potential immunotherapies. Its website also features a product shop and information about the company’s pipeline, alongside details about its vision, mission, and values. The company presents customized collaboration as central to its work, bringing antibody discovery, engineering, and production together to address partner requirements.